Health Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhere
Conditions
Interventions
Intervention1: Maandha Ennai: DOSAGE: 3 5 ml, twice daily for 14 days
ROUTE: Oral administration
Control Intervention1: Varmam Therapy: Varmam Therapy (External) on specified points (Sirunkoolli, Ucch
Sponsors
Dr T GANESAN
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 3 12 yrs, 2.febrile seizures, 3.metabolic seizures, 4.CP with seizures.
Exclusion criteria
Exclusion criteria: 1.Brain tumor, 2.Brain trauma, 3.Meningitis, 4.Lead poisoning, 5.Above 12 yrs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To validate Siddha interventions in seizure management.To provide evidence for anticonvulsant efficacy of Maandha Ennai.To demonstrate neuromuscular stabilizing potential of Varmam Therapy. - To support integrative pediatric epilepsy care with minimal side effects.Timepoint: The study outcomes related to seizure control, anticonvulsant efficacy, neuromuscular stabilization, and safety will be assessed at predefined time points at baseline (Day 0), during treatment (Day 7), and at the end of treatment (Day 14) to validate Siddha interventions in seizure management, evaluate the anticonvulsant efficacy of Maandha Ennai and the neuromuscular stabilizing potential of Varmam Therapy, and support integrative pediatric epilepsy care with minimal side effects. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr K SHYAMALA MD S
Government Siddha Medical College and Hospital,Palayamkottai
Outcome results
None listed